SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2024-03-28 08:46
Tx date 2024-03-27
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-627,818.6196
-126,281 vol
$4.97 each
0
Filed 2024-03-28 08:45
Tx date 2024-03-27
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$627,818
+126,281 vol
$4.97 each
126,281
Filed 2024-03-28 08:44
Tx date 2024-03-26
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-872,665.8048
-175,104 vol
$4.98 each
0
Filed 2024-03-28 08:43
Tx date 2024-03-26
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$872,665
+175,104 vol
$4.98 each
175,104
Filed 2024-03-28 08:42
Tx date 2024-03-25
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-389,583.1116
-78,126 vol
$4.99 each
0
Filed 2024-03-28 08:41
Tx date 2024-03-25
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$389,583
+78,126 vol
$4.99 each
78,126
Older filings
Filed 2024-03-25 09:18
Tx date 2024-03-22
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-994,884.48
-199,776 vol
$4.98 each
0
Filed 2024-03-25 09:18
Tx date 2024-03-22
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$994,884
+199,776 vol
$4.98 each
199,776
Filed 2024-03-08 12:07
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+15,688 vol
101,115
Filed 2024-03-08 12:06
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+9,136 vol
85,427
Filed 2024-03-08 12:05
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-200,110.40
-35,734 vol
$5.60 each
92,284
Filed 2024-03-08 12:00
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-116,569.60
-20,816 vol
$5.60 each
128,018
Filed 2024-03-08 11:52
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+29,459 vol
55,250
Filed 2024-03-08 11:51
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-357,392
-63,820 vol
$5.60 each
229,517
Filed 2024-03-08 11:25
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-1,245,826.40
-222,469 vol
$5.60 each
1,210,556
Filed 2024-03-08 11:20
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-497,982.78
-90,378 vol
$5.51 each
432,116
Filed 2024-03-08 11:19
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-191,158.43
-34,693 vol
$5.51 each
522,494
Filed 2024-03-08 11:10
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+144,781 vol
311,558
Filed 2024-03-08 11:09
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+54,787 vol
166,777
Filed 2024-03-08 11:07
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-1,245,826.40
-222,469 vol
$5.60 each
Filed 2024-03-08 11:05
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-582,848
-104,080 vol
$5.60 each
1,433,025
Filed 2024-03-08 10:54
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+38,952 vol
73,928
Filed 2024-03-08 10:53
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-317,682.40
-56,729 vol
$5.60 each
400,659
Filed 2024-03-08 10:48
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+61,087 vol
151,956
Filed 2024-03-08 10:48
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+23,319 vol
90,869
Filed 2024-03-08 10:45
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-506,116.80
-90,378 vol
$5.60 each
Filed 2024-03-08 10:45
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-506,116.80
-90,378 vol
$5.60 each
432,116
Filed 2024-03-08 10:44
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-194,280.80
-34,693 vol
$5.60 each
Filed 2024-03-08 10:44
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-194,280.80
-34,693 vol
$5.60 each
522,494
Filed 2024-03-08 10:39
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+29,982 vol
78,360
Filed 2024-03-08 10:38
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+15,236 vol
48,378
Filed 2024-03-08 10:37
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-382,312
-68,270 vol
$5.60 each
365,464
Filed 2024-03-08 10:34
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-194,280.80
-34,693 vol
$5.60 each
433,734
Filed 2024-03-08 10:27
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+52,628 vol
112,133
Filed 2024-03-08 10:26
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+23,727 vol
59,505
Filed 2024-03-08 10:23
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-428,248.80
-76,473 vol
$5.60 each
383,795
Filed 2024-03-08 10:21
Tx date 2024-03-06
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-194,280.80
-34,693 vol
$5.60 each
460,268
Filed 2024-02-29 10:46
Tx date 2024-02-27
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$-30,073
-4,930 vol
$6.10 each
25,791
Filed 2024-02-29 09:59
Tx date 2024-02-28
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-57,507.3055
-9,805 vol
$5.87 each
0
Filed 2024-02-29 09:58
Tx date 2024-02-28
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$57,507
+9,805 vol
$5.87 each
9,805
Filed 2024-02-29 09:58
Tx date 2024-02-27
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-125,067.6325
-20,975 vol
$5.96 each
0
Filed 2024-02-29 09:57
Tx date 2024-02-27
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$125,067
+20,975 vol
$5.96 each
20,975
Filed 2024-02-29 09:57
Tx date 2024-02-26
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-1,511,269.1848
-252,653 vol
$5.98 each
0
Filed 2024-02-29 09:56
Tx date 2024-02-26
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,511,269
+252,653 vol
$5.98 each
252,653
Filed 2024-02-26 10:38
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$24,304,900
+4,930 vol
$4,930 each
67,550
Filed 2024-02-26 10:37
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+216,666 vol
557,187
Filed 2024-02-26 10:24
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+29,976 vol
34,976
Filed 2024-02-26 10:22
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+195,512 vol
457,388
Filed 2024-02-26 10:21
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-251,219.64
-45,843 vol
$5.48 each
261,876
Filed 2024-02-26 09:52
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+25,791 vol
30,721
Filed 2024-02-26 09:50
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+4,930 vol
4,930
Filed 2024-02-26 09:49
Tx date 2022-07-18
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-02-26 09:48
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-279,134.76
-50,937 vol
$5.48 each
293,337
Filed 2024-02-26 09:23
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+661,538 vol
1,537,105
Filed 2024-02-26 09:21
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+4,886 vol
111,990
Filed 2024-02-26 09:17
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+71,033 vol
104,000
Filed 2024-02-26 09:11
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-913,822.40
-104,080 vol
$8.78 each
875,567
Filed 2023-03-07 10:32
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+71,330 vol
Filed 2023-03-07 10:31
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-930,475.20
-104,080 vol
$8.94 each
Filed 2024-02-23 16:40
Tx date 2024-02-23
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-1,064,755.9796
-178,372 vol
$5.97 each
0
Filed 2024-02-23 16:40
Tx date 2024-02-23
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,064,755
+178,372 vol
$5.97 each
178,372
Filed 2024-02-23 16:39
Tx date 2024-02-22
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-3,418,183.2384
-587,559 vol
$5.82 each
0
Filed 2024-02-23 16:38
Tx date 2024-02-22
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,418,183
+587,559 vol
$5.82 each
587,559
Filed 2024-02-23 16:37
Tx date 2024-02-21
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$-3,823,204.9466
-683,423 vol
$5.59 each
0
Filed 2024-02-23 16:36
Tx date 2024-02-21
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,823,204
+683,423 vol
$5.59 each
683,423
Filed 2024-02-23 16:33
Tx date 2024-02-21
$AUPH
Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals
1 - Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2024-02-23 11:25
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+194,230 vol
468,427
Filed 2024-02-23 11:23
Tx date 2024-02-20
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+4,217 vol
33,142
Filed 2024-02-23 11:21
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-304,604.54
-34,693 vol
$8.78 each
274,197
Filed 2024-02-23 11:17
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+15,049 vol
26,731
Filed 2023-03-07 09:46
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+15,291 vol
Filed 2023-03-07 09:39
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-310,155.42
-34,693 vol
$8.94 each
Filed 2023-09-27 12:52
Tx date 2023-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
99 - Correction of information

-1,250,000 vol
0
Filed 2023-09-27 12:51
Tx date 2023-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
99 - Correction of information

-3,750,000 vol
32,900
Filed 2023-09-27 12:49
Tx date 2023-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Foster Investments Ltd. (Indirect Ownership)
Common Shares
99 - Correction of information

-4,328,890 vol
0
Filed 2023-09-27 12:48
Tx date 2023-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
99 - Correction of information

-2,006,820 vol
0
Filed 2023-09-25 12:36
Tx date 2023-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+20,383 vol
20,383
Filed 2023-09-25 12:33
Tx date 2009-06-23
$AUPH
Aurinia Pharmaceuticals Inc.
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2023-09-25 12:30
Tx date 2023-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Foster, Robert Thomas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$274,386
+32,900 vol
$8.34 each
3,782,900
Filed 2023-08-22 14:13
Tx date 2023-08-18
$AUPH
Aurinia Pharmaceuticals Inc.
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+17,913 vol
17,913
Filed 2023-08-22 14:12
Tx date 2023-08-18
$AUPH
Aurinia Pharmaceuticals Inc.
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-22 14:11
Tx date 2023-08-18
$AUPH
Aurinia Pharmaceuticals Inc.
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$274,820
+28,959 vol
$9.49 each
28,959
Filed 2023-08-22 14:08
Tx date 2023-08-18
$AUPH
Aurinia Pharmaceuticals Inc.
Bailey, Jeff
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-22 14:00
Tx date 2023-08-18
$AUPH
Aurinia Pharmaceuticals Inc.
Smith, Karen Lesley
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+17,913 vol
17,913
Filed 2023-08-22 13:59
Tx date 2023-08-18
$AUPH
Aurinia Pharmaceuticals Inc.
Smith, Karen Lesley
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-22 13:57
Tx date 2023-08-18
$AUPH
Aurinia Pharmaceuticals Inc.
Smith, Karen Lesley
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$274,820
+28,959 vol
$9.49 each
28,959
Filed 2023-08-22 13:18
Tx date 2023-08-18
$AUPH
Aurinia Pharmaceuticals Inc.
Smith, Karen Lesley
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2023-05-24 15:07
Tx date 2023-05-23
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,461 vol
11,961
Filed 2023-05-24 15:05
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights

-8,733 vol
0
Filed 2023-05-24 15:03
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,733 vol
78,733
Filed 2023-05-24 15:02
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights

-8,733 vol
0
Filed 2023-05-24 14:59
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$163,613
+15,234 vol
$10.74 each
141,193
Filed 2023-05-24 14:57
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+9,310 vol
9,310
Filed 2023-05-24 14:56
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,918 vol
9,218
Filed 2023-05-24 14:53
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights

-8,733 vol
0
Filed 2023-05-24 14:44
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$163,613
+15,234 vol
$10.74 each
186,193
Filed 2023-05-24 14:43
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+9,310 vol
9,310
Filed 2023-05-24 14:41
Tx date 2023-05-23
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-98,333.58
-8,733 vol
$11.26 each
40,000
Filed 2023-05-24 14:40
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,733 vol
48,733
Filed 2023-05-24 14:37
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights

-8,733 vol
0
Filed 2023-05-24 14:30
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$163,613
+15,234 vol
$10.74 each
83,137
Filed 2023-05-24 14:24
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$163,613
+15,234 vol
$10.74 each
156,193
Filed 2023-05-24 14:17
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+4,083 vol
24,083
Filed 2023-05-24 14:13
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights

-8,733 vol
0
Filed 2023-05-24 14:02
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+9,310 vol
9,310
Filed 2023-05-24 14:01
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights

-8,733 vol
Filed 2023-05-24 13:53
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+9,310 vol
9,310
Filed 2023-05-24 13:49
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,733 vol
8,733
Filed 2023-05-24 13:48
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-05-24 13:47
Tx date 2023-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights

-8,733 vol
0
Filed 2023-05-23 19:01
Tx date 2023-05-22
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$-73,233.60
-4,818 vol
$15.20 each
3,915
Filed 2023-05-23 18:58
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$126,628
+8,733 vol
$14.50 each
8,733
Filed 2023-05-23 18:36
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
Common Shares
57 - Exercise of rights
$126,628
+8,733 vol
$14.50 each
Filed 2023-05-23 18:23
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,234 vol
141,193
Filed 2023-05-23 18:21
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+9,310 vol
9,310
Filed 2023-05-23 18:16
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$126,628
+8,733 vol
$14.50 each
Filed 2023-05-23 18:15
Tx date 2019-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-05-23 18:12
Tx date 2023-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights

-8,733 vol
0
Filed 2023-03-07 10:52
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+20,816 vol
76,291
Filed 2023-03-07 10:50
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights

-20,816 vol
148,834
Filed 2023-03-07 10:49
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+107,202 vol
169,650
Filed 2023-03-07 10:44
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$178,283
+20,000 vol
$8.91 each
70,000
Filed 2023-03-07 10:40
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+34,693 vol
62,620
Filed 2023-03-07 10:38
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights

-34,693 vol
340,521
Filed 2023-03-07 10:37
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+271,134 vol
375,214
Filed 2023-03-07 10:34
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+3,104 vol
107,401
Filed 2023-03-07 10:32
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+71,330 vol
104,297
Filed 2023-03-07 10:31
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-930,475.20
-104,080 vol
$8.94 each
875,567
Filed 2023-03-07 10:27
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+667,407 vol
979,647
Filed 2023-03-07 10:21
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+2,399 vol
32,406
Filed 2023-03-07 10:20
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+23,397 vol
30,007
Filed 2023-03-07 10:17
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-310,155.42
-34,693 vol
$8.94 each
298,808
Filed 2023-03-07 10:12
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+229,421 vol
333,501
Filed 2023-03-07 09:48
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+2,194 vol
29,167
Filed 2023-03-07 09:46
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+15,291 vol
26,973
Filed 2023-03-07 09:39
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
57 - Exercise of rights
$-310,155.42
-34,693 vol
$8.94 each
274,197
Filed 2023-03-07 09:20
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+204,810 vol
308,890
Filed 2023-03-07 09:14
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+170,188 vol
307,719
Filed 2023-03-07 09:08
Tx date 2023-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+191,462 vol
344,274
Filed 2022-11-23 16:05
Tx date 2022-11-21
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+1,703 vol
27,927
Filed 2022-11-23 16:04
Tx date 2022-11-21
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$46,600
+10,000 vol
$4.66 each
26,224
Filed 2022-11-15 08:48
Tx date 2022-11-09
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$25,075
+5,000 vol
$5.01 each
5,000
Filed 2022-11-15 08:43
Tx date 2022-07-18
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2022-11-09 16:14
Tx date 2022-11-07
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$154,800
+30,000 vol
$5.16 each
55,475
Filed 2022-08-02 10:00
Tx date 2022-08-01
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+152,812 vol
152,812
Filed 2022-08-02 09:58
Tx date 2022-07-18
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-08-02 09:58
Tx date 2022-08-01
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,101,376
+256,892 vol
$8.18 each
256,892
Filed 2022-08-02 09:51
Tx date 2022-08-01
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+137,531 vol
137,531
Filed 2022-08-02 09:49
Tx date 2022-07-18
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-08-02 09:47
Tx date 2022-08-01
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,891,240
+231,203 vol
$8.18 each
231,203
Filed 2022-07-25 10:44
Tx date 2022-07-18
$AUPH
Aurinia Pharmaceuticals Inc.
Habig, Scott
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-07-25 10:39
Tx date 2022-07-18
$AUPH
Aurinia Pharmaceuticals Inc.
Knappertz, Volker
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-07-11 13:17
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$36,200
+10,000 vol
$3.62 each
40,000
Filed 2022-07-11 13:12
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-47,300
-10,000 vol
$4.73 each
170,959
Filed 2022-05-23 11:35
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$167,307
+14,612 vol
$11.45 each
125,959
Filed 2022-05-23 11:34
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+8,733 vol
8,733
Filed 2022-05-23 11:33
Tx date 2020-04-14
$AUPH
Aurinia Pharmaceuticals Inc.
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 11:30
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$167,307
+14,612 vol
$11.45 each
210,959
Filed 2022-05-23 11:29
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+8,733 vol
8,733
Filed 2022-05-23 11:28
Tx date 2017-05-08
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 11:26
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$167,307
+14,612 vol
$11.45 each
125,959
Filed 2022-05-23 11:24
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+8,733 vol
8,733
Filed 2022-05-23 11:23
Tx date 2019-11-13
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 11:20
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$167,307
+14,612 vol
$11.45 each
180,959
Filed 2022-05-23 11:18
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+8,733 vol
8,733
Filed 2022-05-23 11:17
Tx date 2015-05-26
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 11:14
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$167,307
+14,612 vol
$11.45 each
130,959
Filed 2022-05-23 11:07
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+8,733 vol
8,733
Filed 2022-05-23 11:06
Tx date 2018-02-07
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 11:02
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$167,307
+14,612 vol
$11.45 each
140,959
Filed 2022-05-23 10:59
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+8,733 vol
8,733
Filed 2022-05-23 10:58
Tx date 2019-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-23 10:46
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$167,307
+14,612 vol
$11.45 each
67,903
Filed 2022-05-23 10:40
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+8,733 vol
8,733
Filed 2022-05-23 10:38
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-20 21:25
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+14,612 vol
125,959
Filed 2022-05-20 21:21
Tx date 2022-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+8,733 vol
8,733
Filed 2022-05-20 21:19
Tx date 2019-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-11 19:31
Tx date 2022-03-09
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$54,985
+5,000 vol
$11.00 each
9,400
Filed 2022-03-11 12:05
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,138,536
+178,063 vol
$12.01 each
621,471
Filed 2022-03-07 11:21
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,078,486
+173,063 vol
$12.01 each
Filed 2022-03-08 16:42
Tx date 2022-03-04
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$54,100
+5,000 vol
$10.82 each
50,000
Filed 2022-03-07 22:11
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights
$-102,085
-8,500 vol
$12.01 each
0
Filed 2022-03-07 22:04
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
51 - Exercise of options
$-102,085
-8,500 vol
$12.01 each
0
Filed 2022-03-07 17:47
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,654 vol
90,953
Filed 2022-03-07 17:46
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights
$-102,085
-8,500 vol
$12.01 each
0
Filed 2022-03-07 17:44
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
58 - Expiration of rights

-34,000 vol
8,500
Filed 2022-03-07 17:42
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+8,500 vol
11,682
Filed 2022-03-07 17:41
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights

-8,500 vol
0
Filed 2022-03-07 17:40
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
58 - Expiration of rights

-34,000 vol
8,500
Filed 2022-03-07 17:38
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,440 vol
6,610
Filed 2022-03-07 17:37
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights
$-102,085
-8,500 vol
$12.01 each
0
Filed 2022-03-07 17:27
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
58 - Expiration of rights

-34,000 vol
8,500
Filed 2022-03-07 17:22
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,651 vol
25,475
Filed 2022-03-07 17:20
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights
$-102,085
-8,500 vol
$12.01 each
Filed 2022-03-07 17:20
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights
$-102,085
-8,500 vol
$12.01 each
0
Filed 2022-03-07 17:18
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
58 - Expiration of rights

-34,000 vol
8,500
Filed 2022-03-07 17:15
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+3,651 vol
69,379
Filed 2022-03-07 17:14
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
51 - Exercise of options
$-102,085
-8,500 vol
$12.01 each
0
Filed 2022-03-07 17:14
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
51 - Exercise of options
$-102,085
-8,500 vol
$12.01 each
Filed 2022-03-07 17:11
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
58 - Expiration of rights

-34,000 vol
8,500
Filed 2022-03-07 17:08
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+19,232 vol
32,967
Filed 2022-03-07 17:07
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights
$-339,883
-28,300 vol
$12.01 each
0
Filed 2022-03-07 17:05
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
58 - Expiration of rights

-113,200 vol
28,300
Filed 2022-03-07 16:57
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+5,448 vol
16,224
Filed 2022-03-07 16:51
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights
$-102,085
-8,500 vol
$12.01 each
0
Filed 2022-03-07 16:47
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
58 - Expiration of rights

-34,000 vol
8,500
Filed 2022-03-07 16:34
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$63,592
+5,295 vol
$12.01 each
13,495
Filed 2022-03-07 16:30
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
57 - Exercise of rights
$-102,085
-8,500 vol
$12.01 each
0
Filed 2022-03-07 15:50
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options

+8,500 vol
Filed 2022-03-07 15:50
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options

+8,500 vol
16,700
Filed 2022-03-07 15:47
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
50 - Grant of options

-8,500 vol
0
Filed 2022-03-07 15:47
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
50 - Grant of options

-8,500 vol
Filed 2022-03-07 15:44
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
58 - Expiration of rights

-34,000 vol
8,500
Filed 2022-03-07 15:37
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+312,240 vol
312,240
Filed 2022-03-07 15:36
Tx date 2019-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:34
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+72,856 vol
72,856
Filed 2022-03-07 15:33
Tx date 2013-09-20
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:31
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+104,080 vol
104,080
Filed 2022-03-07 15:21
Tx date 2014-06-16
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:18
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+104,080 vol
104,080
Filed 2022-03-07 15:16
Tx date 2020-04-27
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:13
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+62,448 vol
62,448
Filed 2022-03-07 15:12
Tx date 2013-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:09
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+62,448 vol
62,448
Filed 2022-03-07 15:07
Tx date 2011-08-23
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 15:04
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+104,080 vol
104,080
Filed 2022-03-07 15:00
Tx date 2019-07-17
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 14:58
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
56 - Grant of rights

+104,080 vol
104,080
Filed 2022-03-07 14:37
Tx date 2020-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-07 13:01
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+462 vol
3,182
Filed 2022-03-07 12:56
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+170 vol
1,170
Filed 2022-03-07 12:49
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+282 vol
13,735
Filed 2022-03-07 12:42
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+876 vol
10,776
Filed 2022-03-07 11:32
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$6,415,597
+534,188 vol
$12.01 each
3,363,988
Filed 2022-03-07 11:27
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,496,974
+124,644 vol
$12.01 each
420,734
Filed 2022-03-07 11:21
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,078,486
+173,063 vol
$12.01 each
616,471
Filed 2022-03-07 11:13
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,138,536
+178,063 vol
$12.01 each
631,113
Filed 2022-03-07 11:07
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,283,124
+106,838 vol
$12.01 each
217,363
Filed 2022-03-07 11:02
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,283,124
+106,838 vol
$12.01 each
560,395
Filed 2022-03-07 10:55
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,138,536
+178,063 vol
$12.01 each
791,515
Filed 2022-03-07 10:05
Tx date 2022-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,138,536
+178,063 vol
$12.01 each
850,700
Filed 2022-01-04 17:32
Tx date 2022-01-03
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-14,765.86
-634 vol
$23.29 each
3,500
Filed 2022-01-04 17:32
Tx date 2022-01-03
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-888,884.28
-39,366 vol
$22.58 each
4,134
Filed 2022-01-04 17:29
Tx date 2022-01-03
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$203,200
+40,000 vol
$5.08 each
43,500
Filed 2022-01-04 17:27
Tx date 2022-01-03
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-256,000
-40,000 vol
$6.40 each
116,347
Filed 2021-12-16 10:02
Tx date 2021-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$32,064
+1,600 vol
$20.04 each
5,300
Filed 2021-11-12 16:37
Tx date 2021-11-11
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-324,500
-11,000 vol
$29.50 each
21,824
Filed 2021-11-12 16:36
Tx date 2021-11-11
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-835,780
-29,000 vol
$28.82 each
32,824
Filed 2021-11-12 16:35
Tx date 2021-11-11
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$835,780
+29,000 vol
$28.82 each
61,824
Filed 2021-11-12 16:33
Tx date 2021-11-11
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-702,380
-29,000 vol
$24.22 each
110,525
Filed 2021-11-12 16:31
Tx date 2021-11-10
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-305,500
-10,000 vol
$30.55 each
32,824
Filed 2021-11-12 16:30
Tx date 2021-11-10
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,527,500
-50,000 vol
$30.55 each
42,824
Filed 2021-11-12 16:29
Tx date 2021-11-09
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,508,500
-50,000 vol
$30.17 each
92,824
Filed 2021-11-12 16:02
Tx date 2021-11-11
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,889,000
-100,000 vol
$28.89 each
87,299
Filed 2021-11-12 16:01
Tx date 2021-11-11
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$530,000
+100,000 vol
$5.30 each
187,299
Filed 2021-11-12 16:00
Tx date 2021-11-11
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-652,000
-100,000 vol
$6.52 each
296,090
Filed 2021-11-12 15:58
Tx date 2021-11-10
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-305,500
-10,000 vol
$30.55 each
87,299
Filed 2021-11-12 15:57
Tx date 2021-11-10
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,805,300
-90,000 vol
$31.17 each
97,299
Filed 2021-11-12 15:57
Tx date 2021-11-10
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$159,000
+30,000 vol
$5.30 each
187,299
Filed 2021-11-12 15:56
Tx date 2021-11-10
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-195,600
-30,000 vol
$6.52 each
396,090
Filed 2021-11-12 15:53
Tx date 2021-11-10
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$424,200
+70,000 vol
$6.06 each
157,299
Filed 2021-11-12 15:49
Tx date 2021-11-10
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-562,800
-70,000 vol
$8.04 each
426,090
Filed 2021-11-12 15:41
Tx date 2021-11-09
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,508,500
-50,000 vol
$30.17 each
87,299
Filed 2021-11-04 09:54
Tx date 2021-11-01
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,423,800
-45,000 vol
$31.64 each
142,824
Filed 2021-11-04 09:53
Tx date 2021-11-01
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$144,000
+45,000 vol
$3.20 each
187,824
Filed 2021-11-04 09:45
Tx date 2021-11-01
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-189,450
-45,000 vol
$4.21 each
139,525
Filed 2021-11-04 09:38
Tx date 2021-11-01
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,423,800
-45,000 vol
$31.64 each
137,299
Filed 2021-11-04 09:36
Tx date 2021-11-01
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$238,500
+45,000 vol
$5.30 each
182,299
Filed 2021-11-04 09:34
Tx date 2021-11-01
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-293,400
-45,000 vol
$6.52 each
496,090
Filed 2021-10-27 09:41
Tx date 2021-10-25
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-3,867,500
-130,000 vol
$29.75 each
65,728
Filed 2021-10-27 09:40
Tx date 2021-10-25
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$304,000
+95,000 vol
$3.20 each
195,728
Filed 2021-10-27 09:38
Tx date 2021-10-25
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-399,950
-95,000 vol
$4.21 each
453,557
Filed 2021-09-23 15:12
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,101,750
-87,500 vol
$24.02 each
142,824
Filed 2021-09-23 15:10
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$183,800
+10,000 vol
$18.38 each
230,324
Filed 2021-09-23 15:09
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$424,200
+70,000 vol
$6.06 each
220,324
Filed 2021-09-23 15:09
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$39,750
+7,500 vol
$5.30 each
150,324
Filed 2021-09-23 15:08
Tx date 2021-09-20
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-345,600
-16,000 vol
$21.60 each
142,824
Filed 2021-09-23 15:07
Tx date 2021-09-20
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-271,375
-12,500 vol
$21.71 each
158,824
Filed 2021-09-23 15:05
Tx date 2021-09-20
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$151,050
+28,500 vol
$5.30 each
171,324
Filed 2021-09-23 15:03
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-242,200
-10,000 vol
$24.22 each
184,525
Filed 2021-09-23 15:01
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-562,800
-70,000 vol
$8.04 each
194,525
Filed 2021-09-23 14:58
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-48,900
-7,500 vol
$6.52 each
264,525
Filed 2021-09-23 14:56
Tx date 2021-09-20
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-185,820
-28,500 vol
$6.52 each
272,025
Filed 2021-09-23 14:43
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-126,912.24
-5,364 vol
$23.66 each
100,728
Filed 2021-09-23 14:42
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-652,620.80
-27,136 vol
$24.05 each
106,092
Filed 2021-09-23 14:41
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$35,635
+11,136 vol
$3.20 each
133,228
Filed 2021-09-23 14:40
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$42,080
+16,000 vol
$2.63 each
122,092
Filed 2021-09-23 14:38
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-46,882.56
-11,136 vol
$4.21 each
548,557
Filed 2021-09-23 14:35
Tx date 2021-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-56,000
-16,000 vol
$3.50 each
559,693
Filed 2021-09-17 15:48
Tx date 2021-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-159,300
-30,000 vol
$5.31 each
142,824
Filed 2021-09-17 15:47
Tx date 2021-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-304,220
-14,000 vol
$21.73 each
172,824
Filed 2021-09-17 15:45
Tx date 2021-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$233,639
+44,000 vol
$5.31 each
186,824
Filed 2021-09-17 15:44
Tx date 2021-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-286,880
-44,000 vol
$6.52 each
300,525
Filed 2021-09-17 15:39
Tx date 2021-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-144,000
-45,000 vol
$3.20 each
142,824
Filed 2021-09-17 15:38
Tx date 2021-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$144,000
+45,000 vol
$3.20 each
187,824
Filed 2021-09-17 15:37
Tx date 2021-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-189,450
-45,000 vol
$4.21 each
344,525
Filed 2021-09-17 15:34
Tx date 2021-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-238,950
-45,000 vol
$5.31 each
142,824
Filed 2021-09-17 15:33
Tx date 2021-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$238,949
+45,000 vol
$5.31 each
187,824
Filed 2021-09-17 15:30
Tx date 2021-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-293,400
-45,000 vol
$6.52 each
389,525
Filed 2021-09-17 15:24
Tx date 2021-09-13
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-132,750
-25,000 vol
$5.31 each
142,824
Filed 2021-09-17 15:22
Tx date 2021-09-13
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$132,750
+25,000 vol
$5.31 each
167,824
Filed 2021-09-17 15:18
Tx date 2021-09-13
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-163,000
-25,000 vol
$6.52 each
434,525
Filed 2021-09-16 11:51
Tx date 2021-09-10
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,976,000
-150,000 vol
$19.84 each
137,299
Filed 2021-09-16 11:49
Tx date 2021-09-10
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$480,000
+150,000 vol
$3.20 each
287,299
Filed 2021-09-16 11:45
Tx date 2021-09-13
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-631,500
-150,000 vol
$4.21 each
541,090
Filed 2021-09-15 16:06
Tx date 2021-09-10
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-687,375
-32,500 vol
$21.15 each
106,092
Filed 2021-09-08 15:47
Tx date 2021-09-07
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-91,500
-5,000 vol
$18.30 each
138,592
Filed 2021-09-08 15:37
Tx date 2021-09-07
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-135,750
-7,500 vol
$18.10 each
142,824
Filed 2021-08-27 16:21
Tx date 2021-08-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-400,725
-22,500 vol
$17.81 each
150,324
Filed 2021-08-26 16:26
Tx date 2021-08-25
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-79,250
-5,000 vol
$15.85 each
137,299
Filed 2021-08-10 16:17
Tx date 2021-08-09
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-80,050
-5,000 vol
$16.01 each
172,824
Filed 2021-08-10 16:05
Tx date 2021-08-09
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-721,350
-45,000 vol
$16.03 each
142,299
Filed 2021-07-29 16:27
Tx date 2021-07-28
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-87,073
-5,000 vol
$17.41 each
177,824
Filed 2021-06-23 16:37
Tx date 2021-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-85,050
-5,000 vol
$17.01 each
182,824
Filed 2021-06-18 11:17
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+31,347 vol
111,347
Filed 2021-06-17 17:13
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$403,122
+31,347 vol
$12.86 each
111,347
Filed 2021-06-17 17:09
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$403,122
+31,347 vol
$12.86 each
111,347
Filed 2021-06-17 17:06
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$403,122
+31,347 vol
$12.86 each
166,347
Filed 2021-06-17 17:03
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$403,122
+31,347 vol
$12.86 each
156,347
Filed 2021-06-17 16:59
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$403,122
+31,347 vol
$12.86 each
126,347
Filed 2021-06-17 16:56
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$685,322
+53,291 vol
$12.86 each
53,291
Filed 2021-06-17 16:54
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
Balakrishnan, Brinda
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-06-17 16:50
Tx date 2021-06-14
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$403,122
+31,347 vol
$12.86 each
196,347
Filed 2021-05-12 18:48
Tx date 2021-05-12
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: TFSA (RHM) (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$18,040
+1,600 vol
$11.28 each
1,600
Filed 2021-05-12 18:48
Tx date 2019-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: TFSA (RHM) (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-12 18:45
Tx date 2021-05-12
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$15,764
+1,400 vol
$11.26 each
4,400
Filed 2021-05-12 18:45
Tx date 2021-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$11,140
+1,000 vol
$11.14 each
3,000
Filed 2021-05-12 18:44
Tx date 2021-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,585
+500 vol
$11.17 each
2,000
Filed 2021-05-12 17:26
Tx date 2021-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$99,693
+9,900 vol
$10.07 each
9,900
Filed 2021-05-12 17:25
Tx date 2019-07-17
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-12 17:23
Tx date 2021-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$54,888
+5,125 vol
$10.71 each
13,453
Filed 2021-05-12 17:18
Tx date 2021-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$78,200
+20,000 vol
$3.91 each
187,824
Filed 2021-05-12 17:18
Tx date 2021-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-78,200
-20,000 vol
$3.91 each
459,525
Filed 2021-05-12 16:28
Tx date 2021-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$27,389
+2,500 vol
$10.96 each
3,700
Filed 2021-05-11 17:27
Tx date 2021-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$156,400
+40,000 vol
$3.91 each
143,592
Filed 2021-05-11 17:26
Tx date 2021-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-156,400
-40,000 vol
$3.91 each
575,693
Filed 2021-05-11 16:55
Tx date 2021-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,740
+1,000 vol
$9.74 each
1,000
Filed 2021-03-15 21:52
Tx date 2021-03-11
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

-40,000 vol
187,299
Filed 2021-03-15 21:52
Tx date 2021-03-11
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$156,400
+40,000 vol
$3.91 each
227,299
Filed 2021-03-15 21:51
Tx date 2021-03-11
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-156,400
-40,000 vol
$3.91 each
691,090
Filed 2021-03-09 13:28
Tx date 2021-03-05
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$65,000
+5,000 vol
$13.00 each
45,000
Filed 2021-02-01 19:00
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, ALISON (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,172
+150 vol
$21.15 each
150
Filed 2021-02-01 18:59
Tx date 2019-11-13
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, ALISON (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 18:59
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, LINSEY (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$3,172
+150 vol
$21.15 each
150
Filed 2021-02-01 18:58
Tx date 2019-11-13
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, LINSEY (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 18:58
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, MITCHELL R. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$2,115
+100 vol
$21.15 each
100
Filed 2021-02-01 18:57
Tx date 2019-11-13
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, MITCHELL R. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 18:57
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, DAVID (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$8,460
+400 vol
$21.15 each
400
Filed 2021-02-01 18:56
Tx date 2019-11-13
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Holder: GRAY, DAVID (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 18:56
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$25,380
+1,200 vol
$21.15 each
1,200
Filed 2021-02-01 15:21
Tx date 2020-06-01
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Holder: Shelburne Wood Protection (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$21,240
+1,000 vol
$21.24 each
1,000
Filed 2021-02-01 15:21
Tx date 2019-11-13
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Holder: Shelburne Wood Protection (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 15:12
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$125,850
+15,000 vol
$8.39 each
95,000
Filed 2021-02-01 15:12
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$241,199
+30,000 vol
$8.04 each
80,000
Filed 2021-02-01 15:11
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$346,000
+50,000 vol
$6.92 each
50,000
Filed 2021-02-01 15:10
Tx date 2018-02-21
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-02-01 15:10
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-125,850
-15,000 vol
$8.39 each
30,000
Filed 2021-02-01 15:09
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-241,200
-30,000 vol
$8.04 each
45,000
Filed 2021-02-01 15:08
Tx date 2021-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-346,000
-50,000 vol
$6.92 each
75,000
Filed 2020-06-04 14:24
Tx date 2020-06-01
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,240
+1,000 vol
$21.24 each
Filed 2021-01-29 12:51
Tx date 2021-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,526
+900 vol
$16.14 each
2,720
Filed 2020-12-31 14:37
Tx date 2019-01-11
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-82,450
-19,400 vol
$4.25 each
368,039
Filed 2020-12-31 14:36
Tx date 2019-01-09
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-170,000
-40,000 vol
$4.25 each
387,439
Filed 2020-12-31 14:27
Tx date 2019-12-12
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-92,909.25
-21,861 vol
$4.25 each
330,000
Filed 2020-12-31 14:26
Tx date 2019-09-27
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-78,200
-20,000 vol
$3.91 each
351,861
Filed 2020-12-31 14:25
Tx date 2019-09-27
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-145,000
-20,000 vol
$7.25 each
Filed 2020-12-31 14:25
Tx date 2019-09-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-117,180
-21,000 vol
$5.58 each
Filed 2020-12-31 14:24
Tx date 2019-09-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-89,250
-21,000 vol
$4.25 each
371,861
Filed 2020-12-31 14:22
Tx date 2019-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-192,006.50
-45,178 vol
$4.25 each
392,861
Filed 2020-12-31 10:32
Tx date 2020-12-31
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$39,600
+10,000 vol
$3.96 each
30,000
Filed 2020-12-31 10:32
Tx date 2020-12-31
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-39,600
-10,000 vol
$3.96 each
135,000
Filed 2019-12-17 10:19
Tx date 2019-12-12
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$92,909
+21,861 vol
$4.25 each
Filed 2019-10-01 14:07
Tx date 2019-09-27
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-145,000
-20,000 vol
$7.25 each
Filed 2019-10-01 14:02
Tx date 2019-09-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-117,180
-21,000 vol
$5.58 each
Filed 2019-10-01 14:00
Tx date 2019-09-27
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$78,200
+20,000 vol
$3.91 each
Filed 2019-10-01 13:58
Tx date 2019-09-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$89,250
+21,000 vol
$4.25 each
Filed 2019-05-02 15:50
Tx date 2019-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$192,006
+45,178 vol
$4.25 each
Filed 2020-12-30 16:54
Tx date 2020-12-29
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$30,624
+2,200 vol
$13.92 each
8,200
Filed 2020-12-30 16:53
Tx date 2020-12-28
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$28,580
+2,000 vol
$14.29 each
6,000
Filed 2020-12-30 16:53
Tx date 2020-12-22
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,816
+800 vol
$13.52 each
4,000
Filed 2020-12-30 16:52
Tx date 2020-12-22
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$43,232
+3,200 vol
$13.51 each
3,200
Filed 2020-12-28 14:28
Tx date 2020-12-21
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,076,603
+82,625 vol
$13.03 each
714,003
Filed 2020-12-28 14:19
Tx date 2020-10-23
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
56 - Grant of rights

+42,500 vol
42,500
Filed 2020-12-28 14:18
Tx date 2013-09-14
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
Filed 2020-12-23 19:00
Tx date 2020-12-21
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,882,626
+144,484 vol
$13.03 each
443,408
Filed 2020-12-23 18:55
Tx date 2020-12-21
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,921,117
+224,184 vol
$13.03 each
731,090
Filed 2020-12-23 18:53
Tx date 2020-12-21
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,219,516
+93,593 vol
$13.03 each
615,693
Filed 2020-12-23 18:52
Tx date 2020-08-17
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-140,304.05
-31,529 vol
$4.45 each
522,100
Filed 2020-12-23 18:34
Tx date 2020-12-21
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$3,087,484
+236,952 vol
$13.03 each
613,452
Filed 2020-12-23 18:32
Tx date 2020-12-21
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$4,385,637
+336,580 vol
$13.03 each
672,637
Filed 2020-12-23 18:30
Tx date 2020-12-21
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$10,645,822
+817,024 vol
$13.03 each
2,829,800
Filed 2020-12-23 18:28
Tx date 2020-12-21
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$3,526,048
+270,610 vol
$13.03 each
453,050
Filed 2020-08-20 16:06
Tx date 2020-08-17
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$140,304
+31,529 vol
$4.45 each
Filed 2020-12-21 18:59
Tx date 2020-12-21
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$262,076
+20,000 vol
$13.10 each
40,000
Filed 2020-11-17 14:31
Tx date 2020-11-16
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$4,005,581
+298,924 vol
$13.40 each
298,924
Filed 2020-11-17 14:27
Tx date 2014-06-16
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-28 11:03
Tx date 2020-10-23
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
56 - Grant of rights

+42,500 vol
42,500
Filed 2020-10-28 11:03
Tx date 2013-09-20
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 17:20
Tx date 2020-10-23
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
56 - Grant of rights

+42,500 vol
42,500
Filed 2020-10-26 17:19
Tx date 2019-07-17
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 17:19
Tx date 2020-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$3,063,830
+126,500 vol
$24.22 each
376,500
Filed 2020-10-26 17:17
Tx date 2019-08-19
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,962,500
+250,000 vol
$7.85 each
250,000
Filed 2020-10-26 17:16
Tx date 2019-07-17
$AUPH
Aurinia Pharmaceuticals Inc.
Donley, Matthew
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 15:13
Tx date 2020-10-23
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
56 - Grant of rights

+141,500 vol
141,500
Filed 2020-10-26 15:12
Tx date 2019-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 15:07
Tx date 2020-10-23
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
56 - Grant of rights

+42,500 vol
42,500
Filed 2020-10-26 15:07
Tx date 2020-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 14:58
Tx date 2020-10-23
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
56 - Grant of rights

+42,500 vol
42,500
Filed 2020-10-26 14:58
Tx date 2011-08-23
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 14:55
Tx date 2020-10-23
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
56 - Grant of rights

+42,500 vol
42,500
Filed 2020-10-26 14:54
Tx date 2014-06-16
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
Filed 2020-10-26 14:14
Tx date 2020-10-23
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
56 - Grant of rights

+42,500 vol
42,500
Filed 2020-10-26 14:11
Tx date 2020-04-27
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Rights Performance Award
00 - Opening Balance-Initial SEDI Report
Filed 2020-09-25 18:13
Tx date 2020-09-21
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-731,051.9254
-48,458 vol
$15.09 each
6,499,881
Filed 2020-09-25 18:12
Tx date 2020-09-25
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-731,051.9254
-48,458 vol
$15.09 each
Filed 2020-09-25 18:09
Tx date 2020-09-25
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-731,051.9254
-48,458 vol
$15.09 each
Filed 2020-09-18 18:19
Tx date 2020-09-17
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-727,265.3232
-48,464 vol
$15.01 each
6,548,339
Filed 2020-09-18 18:18
Tx date 2020-09-16
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-2,121,956.7516
-140,553 vol
$15.10 each
6,596,803
Filed 2020-09-18 18:16
Tx date 2020-09-15
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-320,281.4264
-21,316 vol
$15.03 each
6,737,356
Filed 2020-08-20 16:10
Tx date 2020-08-18
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-266,176.40
-14,000 vol
$19.01 each
103,592
Filed 2020-08-20 16:08
Tx date 2020-08-17
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$140,304
+31,529 vol
$4.45 each
117,592
Filed 2020-08-20 16:06
Tx date 2020-08-17
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$140,304
+31,529 vol
$4.45 each
585,158
Filed 2020-07-24 11:25
Tx date 2020-07-22
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-9,844,800
-600,000 vol
$16.41 each
6,758,672
Filed 2020-07-11 19:07
Tx date 2020-07-08
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-211,500
-10,000 vol
$21.15 each
187,299
Filed 2020-06-26 18:00
Tx date 2020-06-23
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-1,307,581.395
-79,825 vol
$16.38 each
7,358,672
Filed 2020-06-16 12:00
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$472,500
+30,000 vol
$15.75 each
80,000
Filed 2020-06-16 11:57
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$472,500
+30,000 vol
$15.75 each
145,000
Filed 2020-06-16 11:55
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$472,500
+30,000 vol
$15.75 each
125,000
Filed 2020-06-16 11:53
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$472,500
+30,000 vol
$15.75 each
165,000
Filed 2020-06-16 11:50
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$472,500
+30,000 vol
$15.75 each
125,000
Filed 2020-06-16 11:47
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$472,500
+30,000 vol
$15.75 each
95,000
Filed 2020-06-16 11:41
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
80,000
Filed 2020-06-16 11:24
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$472,500
+30,000 vol
$15.75 each
80,000
Filed 2020-06-03 20:26
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
Filed 2020-06-03 20:25
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
Filed 2020-06-03 20:24
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
Filed 2020-06-03 20:22
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
Filed 2020-06-03 14:40
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
Filed 2020-06-03 14:35
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
Filed 2020-06-03 14:31
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
Filed 2020-06-03 14:27
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
Filed 2020-06-04 14:24
Tx date 2020-06-01
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,240
+1,000 vol
$21.24 each
1,000
Filed 2020-06-03 20:26
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
80,000
Filed 2020-06-03 20:25
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+30,000 vol
80,000
Filed 2020-06-03 20:24
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
125,000
Filed 2020-06-03 20:22
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
125,000
Filed 2020-06-03 14:40
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
95,000
Filed 2020-06-03 14:35
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
80,000
Filed 2020-06-03 14:31
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
165,000
Filed 2020-06-03 14:27
Tx date 2020-06-02
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$642,300
+30,000 vol
$21.41 each
145,000
Filed 2020-05-25 16:02
Tx date 2020-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$69,822
+16,200 vol
$4.31 each
20,000
Filed 2020-05-25 15:59
Tx date 2020-05-19
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options
$-69,822
-16,200 vol
$4.31 each
115,000
Filed 2020-05-25 15:48
Tx date 2020-05-21
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,189,000
+50,000 vol
$23.78 each
182,440
Filed 2020-05-20 10:57
Tx date 2020-05-13
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-331,934.5191
-18,399 vol
$18.04 each
3,354,918
Filed 2020-05-20 10:55
Tx date 2020-05-12
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-697,963.14
-37,575 vol
$18.58 each
3,373,317
Filed 2020-05-15 18:20
Tx date 2020-05-11
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-3,627,600
-200,000 vol
$18.14 each
7,438,497
Filed 2020-05-11 15:39
Tx date 2020-05-07
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-1,707,010
-100,000 vol
$17.07 each
7,638,497
Filed 2020-05-11 15:38
Tx date 2020-05-06
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-1,883,659.2057
-110,151 vol
$17.10 each
7,738,497
Filed 2020-05-11 15:36
Tx date 2020-05-05
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-2,814,138.1478
-162,302 vol
$17.34 each
7,848,648
Filed 2020-05-11 15:32
Tx date 2019-12-27
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

+430,000 vol
3,410,892
Filed 2020-05-11 15:29
Tx date 2019-12-23
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

+2,980,892 vol
2,980,892
Filed 2020-05-11 15:24
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-01 19:18
Tx date 2020-04-28
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$3,032,876
+132,440 vol
$22.90 each
132,440
Filed 2020-05-01 19:12
Tx date 2020-04-27
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-05-01 19:10
Tx date 2020-04-27
$AUPH
Aurinia Pharmaceuticals Inc.
Miller, Joseph
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-04-21 17:37
Tx date 2020-04-14
$AUPH
Aurinia Pharmaceuticals Inc.
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$1,070,500
+50,000 vol
$21.41 each
50,000
Filed 2020-04-21 17:32
Tx date 2020-04-14
$AUPH
Aurinia Pharmaceuticals Inc.
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-04-21 17:30
Tx date 2020-04-14
$AUPH
Aurinia Pharmaceuticals Inc.
Walbert, Timothy
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-04-11 12:46
Tx date 2020-04-09
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-86,279.17
-4,100 vol
$21.04 each
197,299
Filed 2020-04-10 01:44
Tx date 2020-04-07
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-19,413
-900 vol
$21.57 each
201,399
Filed 2020-04-10 01:42
Tx date 2020-04-06
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-316,617
-15,000 vol
$21.11 each
202,299
Filed 2020-03-17 17:46
Tx date 2020-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-17 17:45
Tx date 2020-03-10
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$6,761,466
+336,057 vol
$20.12 each
336,057
Filed 2020-03-17 17:43
Tx date 2020-03-02
$AUPH
Aurinia Pharmaceuticals Inc.
Colao, Massimiliano
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-03-14 19:08
Tx date 2020-03-10
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,275,307
-60,700 vol
$21.01 each
217,299
Filed 2020-02-15 09:25
Tx date 2020-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$947,002
+39,100 vol
$24.22 each
260,906
Filed 2020-02-06 19:10
Tx date 2020-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,692,978
+69,900 vol
$24.22 each
506,906
Filed 2020-02-06 17:33
Tx date 2020-02-05
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$10,645,493
+412,776 vol
$25.79 each
2,012,776
Filed 2020-02-05 14:53
Tx date 2020-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,620,318
+66,900 vol
$24.22 each
631,378
Filed 2020-02-05 13:39
Tx date 2020-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,181,936
+48,800 vol
$24.22 each
566,300
Filed 2020-02-05 13:21
Tx date 2020-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,479,842
+61,100 vol
$24.22 each
553,629
Filed 2020-02-04 18:09
Tx date 2020-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,688,134
+69,700 vol
$24.22 each
598,037
Filed 2020-01-31 20:33
Tx date 2020-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,170,352.88
-63,194 vol
$18.52 each
4,000
Filed 2020-01-31 20:31
Tx date 2020-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$266,046
+63,194 vol
$4.21 each
67,194
Filed 2020-01-31 20:29
Tx date 2020-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-266,046.74
-63,194 vol
$4.21 each
221,806
Filed 2020-01-22 15:05
Tx date 2020-01-22
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$9,408
+500 vol
$18.82 each
1,500
Filed 2020-01-06 08:21
Tx date 2020-01-02
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,050,500
-50,000 vol
$21.01 each
4,000
Filed 2020-01-06 08:21
Tx date 2020-01-02
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$183,000
+50,000 vol
$3.66 each
54,000
Filed 2020-01-06 08:18
Tx date 2020-01-02
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-183,000
-50,000 vol
$3.66 each
285,000
Filed 2020-01-05 20:37
Tx date 2020-01-02
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-82,860
-3,000 vol
$27.62 each
70,891
Filed 2019-12-20 19:11
Tx date 2019-12-19
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$9,298
+500 vol
$18.60 each
1,000
Filed 2019-12-20 19:10
Tx date 2019-12-19
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$9,353
+500 vol
$18.71 each
500
Filed 2019-12-20 19:10
Tx date 2019-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Holder: Renfrew Dieppe Holdings Corporation (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-20 18:38
Tx date 2019-12-17
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,325,800
-70,000 vol
$18.94 each
86,063
Filed 2019-12-20 18:36
Tx date 2019-12-17
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$425,034
+100,008 vol
$4.25 each
156,063
Filed 2019-12-20 18:35
Tx date 2019-12-17
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-100,008 vol
492,529
Filed 2019-12-17 17:54
Tx date 2019-12-16
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-120,400
-5,000 vol
$24.08 each
73,891
Filed 2019-12-17 17:53
Tx date 2019-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,362,000
-75,000 vol
$18.16 each
78,891
Filed 2019-12-17 17:52
Tx date 2019-12-12
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-122,750
-5,000 vol
$24.55 each
16,452
Filed 2019-12-17 17:49
Tx date 2019-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$584,115
+137,439 vol
$4.25 each
153,891
Filed 2019-12-17 17:46
Tx date 2019-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-137,439 vol
528,337
Filed 2019-12-17 10:24
Tx date 2019-12-12
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

+20,000 vol
167,824
Filed 2019-12-17 10:23
Tx date 2019-12-12
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market

+20,000 vol
Filed 2019-12-17 10:21
Tx date 2019-12-12
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market

+20,000 vol
Filed 2019-12-17 10:19
Tx date 2019-12-12
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$92,909
+21,861 vol
$4.25 each
564,478
Filed 2019-12-16 21:47
Tx date 2019-12-11
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-3,625,680
-200,000 vol
$18.13 each
8,010,950
Filed 2019-12-16 18:18
Tx date 2019-12-12
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-483,040
-20,000 vol
$24.15 each
277,999
Filed 2019-12-16 14:41
Tx date 2019-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,253,340.27
-68,601 vol
$18.27 each
4,000
Filed 2019-12-16 14:40
Tx date 2019-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$251,079
+68,601 vol
$3.66 each
72,601
Filed 2019-12-16 14:39
Tx date 2019-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-251,079.66
-68,601 vol
$3.66 each
335,000
Filed 2019-12-16 14:13
Tx date 2019-12-12
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-202,290
-11,000 vol
$18.39 each
4,000
Filed 2019-12-11 11:05
Tx date 2019-09-06
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
Total Return Swap
70 - Acquisition or disposition (writing) of third party derivative

+1 vol
1
Filed 2019-12-11 11:02
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Total Return Swap
00 - Opening Balance-Initial SEDI Report
1
Filed 2019-12-09 17:10
Tx date 2019-12-09
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-12,436,240
-800,000 vol
$15.55 each
8,210,950
Filed 2019-12-09 17:08
Tx date 2019-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-16,874,000
-1,100,000 vol
$15.34 each
9,010,950
Filed 2019-12-09 17:06
Tx date 2019-12-05
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-9,065,831.58
-541,567 vol
$16.74 each
10,110,950
Filed 2019-12-09 17:05
Tx date 2019-11-27
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-358,000
-50,000 vol
$7.16 each
10,652,517
Filed 2019-12-09 15:35
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Direct Ownership
Total Return Swap
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-26 19:46
Tx date 2019-11-26
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-1,377,360
-200,000 vol
$6.89 each
10,702,517
Filed 2019-11-26 19:44
Tx date 2019-11-25
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-612,740
-100,000 vol
$6.13 each
10,902,517
Filed 2019-11-26 19:38
Tx date 2019-11-22
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-24,519.60
-3,892 vol
$6.30 each
11,002,517
Filed 2019-11-26 19:36
Tx date 2019-11-21
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-615,210
-100,000 vol
$6.15 each
11,006,409
Filed 2019-11-21 18:26
Tx date 2019-11-19
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$379,500
+50,000 vol
$7.59 each
50,000
Filed 2019-11-21 18:19
Tx date 2019-11-13
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-21 18:17
Tx date 2019-11-13
$AUPH
Aurinia Pharmaceuticals Inc.
Leversage, Jill Diane
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-21 13:27
Tx date 2019-10-16
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$49,600
+10,000 vol
$4.96 each
20,000
Filed 2019-10-17 12:18
Tx date 2019-10-11
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

-196,200 vol
147,824
Filed 2019-10-15 16:34
Tx date 2019-10-15
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$38,308
+8,328 vol
$4.60 each
8,328
Filed 2019-10-15 16:30
Tx date 2019-10-15
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,510
+2,000 vol
$4.75 each
3,500
Filed 2019-10-15 16:29
Tx date 2019-10-11
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,803
+1,500 vol
$3.87 each
1,500
Filed 2019-10-15 16:28
Tx date 2018-02-07
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-10-14 17:11
Tx date 2019-10-14
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,350
+5,000 vol
$3.87 each
15,000
Filed 2019-10-10 23:42
Tx date 2019-10-10
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,204
+3,800 vol
$5.58 each
344,024
Filed 2019-10-10 13:46
Tx date 2019-10-10
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$8,506
+2,000 vol
$4.25 each
2,000
Filed 2019-10-02 11:48
Tx date 2019-09-30
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$16,169
+3,000 vol
$5.39 each
10,000
Filed 2019-10-01 14:07
Tx date 2019-09-27
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-145,000
-20,000 vol
$7.25 each
542,617
Filed 2019-10-01 14:02
Tx date 2019-09-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-117,180
-21,000 vol
$5.58 each
542,617
Filed 2019-10-01 14:00
Tx date 2019-09-27
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$78,200
+20,000 vol
$3.91 each
562,617
Filed 2019-10-01 13:58
Tx date 2019-09-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$89,250
+21,000 vol
$4.25 each
563,617
Filed 2019-09-26 10:58
Tx date 2019-09-26
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,812
+1,050 vol
$7.44 each
1,820
Filed 2019-07-09 18:43
Tx date 2019-07-08
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$16,377
+3,800 vol
$4.31 each
3,800
Filed 2019-07-09 18:42
Tx date 2015-05-26
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-07-09 18:41
Tx date 2019-07-08
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options

-3,800 vol
131,200
Filed 2019-07-08 19:12
Tx date 2019-07-08
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$63,201
+10,000 vol
$6.32 each
10,000
Filed 2019-07-08 19:10
Tx date 2017-05-08
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-07-05 15:18
Tx date 2019-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
50,000
Filed 2019-07-05 13:12
Tx date 2019-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$125,850
+15,000 vol
$8.39 each
135,000
Filed 2019-07-05 13:02
Tx date 2019-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$125,850
+15,000 vol
$8.39 each
65,000
Filed 2019-07-05 12:46
Tx date 2019-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$125,850
+15,000 vol
$8.39 each
95,000
Filed 2019-07-05 12:37
Tx date 2019-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$125,850
+15,000 vol
$8.39 each
135,000
Filed 2019-07-05 12:33
Tx date 2019-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$125,850
+15,000 vol
$8.39 each
135,000
Filed 2019-07-05 12:26
Tx date 2019-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$125,850
+15,000 vol
$8.39 each
95,000
Filed 2019-07-03 19:20
Tx date 2019-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
Filed 2019-07-03 19:20
Tx date 2019-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
15,000
Filed 2019-07-03 19:14
Tx date 2019-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
MacKay-Dunn, R. Hector
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-07-03 12:56
Tx date 2019-07-01
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-9,772.97
-1,483 vol
$6.59 each
0
Filed 2019-07-01 17:56
Tx date 2019-07-01
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,200
+2,000 vol
$6.60 each
7,000
Filed 2019-05-06 12:40
Tx date 2019-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$84,500
+10,000 vol
$8.45 each
120,000
Filed 2019-05-03 20:07
Tx date 2019-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$422,499
+50,000 vol
$8.45 each
50,000
Filed 2019-05-03 20:02
Tx date 2019-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-03 20:00
Tx date 2019-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
BILLEN, DANIEL
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
20,000
Filed 2019-05-03 19:46
Tx date 2019-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$13,519,999
+1,600,000 vol
$8.45 each
1,600,000
Filed 2019-05-03 19:39
Tx date 2019-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-03 19:36
Tx date 2019-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
GREENLEAF, PETER
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-02 15:59
Tx date 2018-12-18
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

-3,499 vol
435,200
Filed 2019-05-02 15:58
Tx date 2018-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$7,498
+3,499 vol
$2.14 each
Filed 2019-05-02 15:54
Tx date 2019-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market

-45,178 vol
340,224
Filed 2019-05-02 15:50
Tx date 2019-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$192,006
+45,178 vol
$4.25 each
542,617
Filed 2018-12-13 19:37
Tx date 2018-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$7,498
+3,499 vol
$2.14 each
Filed 2019-04-26 18:49
Tx date 2019-04-25
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-293,285.452
-34,733 vol
$8.44 each
253,266
Filed 2019-04-26 18:48
Tx date 2019-04-23
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-85,279
-10,000 vol
$8.53 each
287,999
Filed 2019-04-26 18:45
Tx date 2019-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$190,115
+44,733 vol
$4.25 each
297,999
Filed 2019-04-26 18:42
Tx date 2019-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-190,115.25
-44,733 vol
$4.25 each
437,006
Filed 2019-04-11 12:39
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN Steel Co., Ltd. (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-11 12:38
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN Steel Co., Ltd. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

+1,621,271 vol
1,621,271
Filed 2019-04-11 12:37
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN Steel Co., Ltd. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-04-11 12:17
Tx date 2018-02-14
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
54 - Exercise of warrants
$468,674
+145,533 vol
$3.22 each
10,513,189
Filed 2019-04-11 12:16
Tx date 2018-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
54 - Exercise of warrants
$1,483,050
+593,220 vol
$2.50 each
11,106,409
Filed 2019-04-11 12:15
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

-1,621,271 vol
10,367,656
Filed 2019-04-11 12:14
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
11 - Acquisition or disposition carried out privately

-811,111 vol
11,988,927
Filed 2019-04-11 12:13
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
12,800,038
Filed 2019-04-11 12:12
Tx date 2019-02-14
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Warrants
54 - Exercise of warrants

-145,533 vol
666,666
Filed 2019-04-11 12:11
Tx date 2018-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Warrants
54 - Exercise of warrants

-593,220 vol
812,199
Filed 2019-04-11 12:06
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Huh, Chin Kyu
3 - 10% Security Holder of Issuer
Holder: ILJIN SNT Co., Ltd. (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report
1,405,419
Filed 2019-04-05 19:32
Tx date 2019-04-03
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-90,864
-10,000 vol
$9.09 each
297,999
Filed 2019-04-03 12:16
Tx date 2019-04-01
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-301,500
-45,000 vol
$6.70 each
5,000
Filed 2019-04-03 12:15
Tx date 2019-04-01
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$164,700
+45,000 vol
$3.66 each
50,000
Filed 2019-04-03 12:13
Tx date 2019-04-01
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-164,700
-45,000 vol
$3.66 each
403,601
Filed 2019-03-04
Tx date 2019-03-01
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-436,475
-102,700 vol
$4.25 each
481,739
Filed 2019-03-04
Tx date 2019-02-27
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-449,952
-48,000 vol
$9.37 each
334,099
Filed 2019-03-04
Tx date 2019-02-27
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-440,578
-47,000 vol
$9.37 each
Filed 2019-03-04
Tx date 2019-03-01
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-609,280
-68,000 vol
$8.96 each
231,399
Filed 2019-03-04
Tx date 2019-02-28
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-311,977.29
-34,700 vol
$8.99 each
299,399
Filed 2019-03-04
Tx date 2019-03-04
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-227,826.90
-26,100 vol
$8.73 each
307,999
Filed 2019-03-04
Tx date 2019-03-01
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$436,475
+102,700 vol
$4.25 each
334,099
Filed 2019-03-03
Tx date 2019-02-27
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-440,578
-47,000 vol
$9.37 each
335,099
Filed 2019-02-20
Tx date 2019-02-15
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$32,599
+5,000 vol
$6.52 each
355,000
Filed 2019-02-20
Tx date 2019-02-12
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$33,680
+8,000 vol
$4.21 each
358,000
Filed 2019-02-20
Tx date 2019-02-12
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-33,680
-8,000 vol
$4.21 each
350,000
Filed 2019-02-20
Tx date 2019-02-15
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-32,600
-5,000 vol
$6.52 each
350,000
Filed 2019-02-11
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$241,199
+30,000 vol
$8.04 each
110,000
Filed 2019-02-08
Tx date 2019-02-04
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-87,175
-10,000 vol
$8.72 each
382,099
Filed 2019-02-02
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$562,799
+70,000 vol
$8.04 each
584,439
Filed 2019-02-02
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$703,499
+87,500 vol
$8.04 each
295,695
Filed 2019-02-01
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Rovinski, Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$241,199
+30,000 vol
$8.04 each
130,000
Filed 2019-02-01
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$562,799
+70,000 vol
$8.04 each
592,537
Filed 2019-02-01
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$241,199
+30,000 vol
$8.04 each
80,000
Filed 2019-02-01
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$241,199
+30,000 vol
$8.04 each
120,000
Filed 2019-02-01
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$241,199
+30,000 vol
$8.04 each
110,000
Filed 2019-02-01
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$241,199
+30,000 vol
$8.04 each
120,000
Filed 2019-02-01
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$562,799
+70,000 vol
$8.04 each
448,601
Filed 2019-02-01
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$241,199
+30,000 vol
$8.04 each
80,000
Filed 2019-02-01
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$703,499
+87,500 vol
$8.04 each
517,500
Filed 2019-02-01
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$562,799
+70,000 vol
$8.04 each
665,776
Filed 2019-02-01
Tx date 2019-02-01
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$562,799
+70,000 vol
$8.04 each
497,439
Filed 2019-01-31
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,600
-2,000 vol
$8.30 each
392,099
Filed 2019-01-31
Tx date 2019-01-28
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-64,584
-8,000 vol
$8.07 each
394,099
Filed 2019-01-29
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$25,110
+3,100 vol
$8.10 each
113,789
Filed 2019-01-29
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$29,970
+3,700 vol
$8.10 each
1,021,206
Filed 2019-01-29
Tx date 2019-01-29
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$9,720
+1,200 vol
$8.10 each
110,689
Filed 2019-01-13
Tx date 2019-01-09
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-33,680
-8,000 vol
$4.21 each
350,000
Filed 2019-01-13
Tx date 2019-01-08
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-65,200
-10,000 vol
$6.52 each
350,000
Filed 2019-01-13
Tx date 2019-01-09
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$33,680
+8,000 vol
$4.21 each
358,000
Filed 2019-01-13
Tx date 2019-01-08
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$65,199
+10,000 vol
$6.52 each
360,000
Filed 2019-01-13
Tx date 2019-01-08
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-50,000
-12,500 vol
$4.00 each
350,000
Filed 2019-01-13
Tx date 2019-01-08
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$50,000
+12,500 vol
$4.00 each
362,500
Filed 2019-01-11
Tx date 2019-01-09
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$73,950
+17,400 vol
$4.25 each
406,301
Filed 2019-01-11
Tx date 2019-01-10
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-19,720
-2,000 vol
$9.86 each
388,901
Filed 2019-01-11
Tx date 2019-01-10
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$8,500
+2,000 vol
$4.25 each
390,901
Filed 2019-01-11
Tx date 2019-01-09
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-72,200
-7,600 vol
$9.50 each
388,901
Filed 2019-01-11
Tx date 2019-01-07
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-379,200
-40,000 vol
$9.48 each
396,501
Filed 2019-01-11
Tx date 2019-01-07
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$170,000
+40,000 vol
$4.25 each
436,501
Filed 2019-01-11
Tx date 2019-01-07
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-162,177.14
-17,198 vol
$9.43 each
396,501
Filed 2019-01-11
Tx date 2019-01-09
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-164,952
-17,400 vol
$9.48 each
388,901
Filed 2019-01-07
Tx date 2019-01-02
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-233,000
-25,000 vol
$9.32 each
413,699
Filed 2019-01-03
Tx date 2018-12-28
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,456.40
-220 vol
$6.62 each
9,180
Filed 2018-12-27
Tx date 2018-12-24
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-26,219.90
-3,500 vol
$7.49 each
402,099
Filed 2018-12-20
Tx date 2018-12-14
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Warrants
37 - Stock split or consolidation

-171,477 vol
3,500
Filed 2018-12-20
Tx date 2018-12-14
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-3,500 vol
0
Filed 2018-12-20
Tx date 2018-12-14
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$7,490
+3,500 vol
$2.14 each
405,599
Filed 2018-12-18
Tx date 2018-12-18
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,650
+1,000 vol
$7.65 each
21,452
Filed 2018-12-14
Tx date 2013-09-20
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
3,500
Filed 2018-12-14
Tx date 2018-12-10
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
Warrants
54 - Exercise of warrants
$-7,499.80
-3,500 vol
$2.14 each
0
Filed 2018-12-14
Tx date 2018-12-10
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
Common Shares
54 - Exercise of warrants
$7,499
+3,500 vol
$2.14 each
109,489
Filed 2018-12-13
Tx date 2018-12-07
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$42,500
+10,000 vol
$4.25 each
29,252
Filed 2018-12-13
Tx date 2018-12-07
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-10,000 vol
595,776
Filed 2018-12-13
Tx date 2018-12-07
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,600
-2,000 vol
$6.30 each
27,252
Filed 2018-12-13
Tx date 2018-12-07
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-57,460
-6,800 vol
$8.45 each
20,452
Filed 2018-12-13
Tx date 2018-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-7,498.357
-3,499 vol
$2.14 each
1
Filed 2018-12-13
Tx date 2018-12-13
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$7,498
+3,499 vol
$2.14 each
3,500
Filed 2018-12-10
Tx date 2018-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$60,189
+9,583 vol
$6.28 each
Filed 2018-12-10
Tx date 2018-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$40,344
+9,583 vol
$4.21 each
11,066
Filed 2018-12-10
Tx date 2018-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-48,611 vol
225,889
Filed 2018-12-10
Tx date 2018-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$32,038
+8,111 vol
$3.95 each
9,594
Filed 2018-12-10
Tx date 2018-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$316,943
+48,611 vol
$6.52 each
50,094
Filed 2018-12-10
Tx date 2018-12-07
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-124,200
-20,000 vol
$6.21 each
5,000
Filed 2018-12-10
Tx date 2018-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-50,944.3799
-8,111 vol
$6.28 each
1,483
Filed 2018-12-10
Tx date 2018-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-9,583 vol
208,195
Filed 2018-12-10
Tx date 2018-12-07
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-73,200
-20,000 vol
$3.66 each
378,601
Filed 2018-12-10
Tx date 2018-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-8,111 vol
217,778
Filed 2018-12-10
Tx date 2018-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-305,320.8299
-48,611 vol
$6.28 each
1,483
Filed 2018-12-10
Tx date 2018-12-06
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-60,189.8647
-9,583 vol
$6.28 each
1,483
Filed 2018-12-10
Tx date 2018-12-07
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-73,200
-20,000 vol
$3.66 each
Filed 2018-12-10
Tx date 2018-12-07
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$73,200
+20,000 vol
$3.66 each
25,000
Filed 2018-11-17
Tx date 2018-11-15
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-154,982.64
-22,200 vol
$6.98 each
402,099
Filed 2018-11-17
Tx date 2018-11-13
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-100,805.76
-14,400 vol
$7.00 each
424,299
Filed 2018-10-15
Tx date 2018-10-11
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Rashieda Gluck I.R.A. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-3,402
-600 vol
$5.67 each
0
Filed 2018-10-15
Tx date 2018-10-11
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-25,695
-4,500 vol
$5.71 each
0
Filed 2018-10-15
Tx date 2018-10-11
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Franklin T Gluck I.R.A. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-5,690
-1,000 vol
$5.69 each
0
Filed 2018-06-20
Tx date 2018-06-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,172
+700 vol
$5.96 each
4,500
Filed 2018-06-12
Tx date 2016-01-04
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Franklin T Gluck I.R.A. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
1,000
Filed 2018-06-12
Tx date 2018-06-07
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

-1,483 vol
0
Filed 2018-06-12
Tx date 2018-06-07
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$21,660
+3,800 vol
$5.70 each
3,800
Filed 2018-06-12
Tx date 2016-01-04
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Rashieda Gluck I.R.A. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
600
Filed 2018-06-12
Tx date 2018-06-07
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$4,107
+1,483 vol
$2.77 each
1,483
Filed 2018-06-07
Tx date 2018-05-30
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-1,483 vol
0
Filed 2018-06-07
Tx date 2018-05-29
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-1,483 vol
0
Filed 2018-06-07
Tx date 2018-05-29
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$4,107
+1,483 vol
$2.77 each
56,055
Filed 2018-06-07
Tx date 2018-05-30
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$4,107
+1,483 vol
$2.77 each
19,252
Filed 2018-05-30
Tx date 2018-05-23
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$205,403
+74,153 vol
$2.77 each
Filed 2018-05-30
Tx date 2018-05-25
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-205,401.04
-74,152 vol
$2.77 each
0
Filed 2018-05-30
Tx date 2018-05-25
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-222,222.50
-88,889 vol
$2.50 each
74,152
Filed 2018-05-30
Tx date 2018-05-25
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$205,403
+74,153 vol
$2.77 each
1,017,506
Filed 2018-05-30
Tx date 2018-05-25
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Control or Direction)
Common Shares
54 - Exercise of warrants
$222,222
+88,889 vol
$2.50 each
105,989
Filed 2018-05-21
Tx date 2018-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$135,600
+40,000 vol
$3.39 each
65,000
Filed 2018-05-21
Tx date 2018-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-22,500 vol
274,500
Filed 2018-05-21
Tx date 2018-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-23,000 vol
297,000
Filed 2018-05-21
Tx date 2018-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-40,000 vol
320,000
Filed 2018-05-21
Tx date 2018-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options
$-129,750
-25,000 vol
$5.19 each
360,000
Filed 2018-05-21
Tx date 2018-05-21
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-56,525.40
-9,300 vol
$6.08 each
0
Filed 2018-05-21
Tx date 2018-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-616,308
-101,200 vol
$6.09 each
9,300
Filed 2018-05-21
Tx date 2018-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$94,725
+22,500 vol
$4.21 each
110,500
Filed 2018-05-21
Tx date 2018-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$129,750
+25,000 vol
$5.19 each
25,000
Filed 2018-05-21
Tx date 2018-03-27
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-23,850
-4,500 vol
$5.30 each
0
Filed 2018-05-21
Tx date 2018-03-27
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-5,290
-1,000 vol
$5.29 each
0
Filed 2018-05-21
Tx date 2018-05-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$90,850
+23,000 vol
$3.95 each
88,000
Filed 2018-03-28
Tx date 2018-03-21
$AUPH
Aurinia Pharmaceuticals Inc.
Demers, Ronald Victor
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-28
Tx date 2018-03-21
$AUPH
Aurinia Pharmaceuticals Inc.
Demers, Ronald Victor
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,059,000
+150,000 vol
$7.06 each
150,000
Filed 2018-03-28
Tx date 2018-03-21
$AUPH
Aurinia Pharmaceuticals Inc.
Demers, Ronald Victor
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,059,000
+150,000 vol
$7.06 each
Filed 2018-03-02
Tx date 2018-02-21
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-02
Tx date 2018-02-22
$AUPH
Aurinia Pharmaceuticals Inc.
Hayden, Michael Reuben
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$346,000
+50,000 vol
$6.92 each
50,000
Filed 2018-02-14
Tx date 2018-02-09
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$320,000
+50,000 vol
$6.40 each
50,000
Filed 2018-02-14
Tx date 2018-02-07
$AUPH
Aurinia Pharmaceuticals Inc.
Hagan, Joseph Patrick
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-02-13
Tx date 2018-02-01
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,467,000
+225,000 vol
$6.52 each
522,537
Filed 2018-02-09
Tx date 2018-02-05
$AUPH
Aurinia Pharmaceuticals Inc.
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$192,600
+30,000 vol
$6.42 each
90,000
Filed 2018-02-09
Tx date 2018-02-05
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$192,600
+30,000 vol
$6.42 each
80,000
Filed 2018-02-09
Tx date 2018-02-05
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$192,600
+30,000 vol
$6.42 each
90,000
Filed 2018-02-07
Tx date 2018-02-05
$AUPH
Aurinia Pharmaceuticals Inc.
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$192,600
+30,000 vol
$6.42 each
80,000
Filed 2018-02-07
Tx date 2018-02-01
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$977,999
+150,000 vol
$6.52 each
398,601
Filed 2018-02-07
Tx date 2018-02-01
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,141,000
+175,000 vol
$6.52 each
385,000
Filed 2018-02-06
Tx date 2018-02-01
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,304,000
+200,000 vol
$6.52 each
350,000
Filed 2018-02-06
Tx date 2018-02-05
$AUPH
Aurinia Pharmaceuticals Inc.
Rovinski, Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$192,600
+30,000 vol
$6.42 each
100,000
Filed 2018-02-06
Tx date 2018-02-01
$AUPH
Aurinia Pharmaceuticals Inc.
Mandt, Lawrence Dean
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$488,999
+75,000 vol
$6.52 each
140,877
Filed 2018-02-06
Tx date 2018-02-05
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$2,568,000
+400,000 vol
$6.42 each
1,670,000
Filed 2018-02-06
Tx date 2018-02-01
$AUPH
Aurinia Pharmaceuticals Inc.
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$977,999
+150,000 vol
$6.52 each
430,000
Filed 2018-02-06
Tx date 2018-02-01
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$977,999
+150,000 vol
$6.52 each
605,776
Filed 2018-02-04
Tx date 2018-02-01
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$1,141,000
+175,000 vol
$6.52 each
514,439
Filed 2018-02-03
Tx date 2018-01-30
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$2,760
+500 vol
$5.52 each
500
Filed 2018-02-03
Tx date 2018-01-31
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$2,640
+500 vol
$5.28 each
1,000
Filed 2018-02-03
Tx date 2018-02-01
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$977,999
+150,000 vol
$6.52 each
427,439
Filed 2017-12-15
Tx date 2017-12-15
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,172
+250 vol
$4.69 each
9,400
Filed 2017-12-04
Tx date 2017-11-20
$AUPH
Aurinia Pharmaceuticals Inc.
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,456
+3,800 vol
$5.12 each
3,800
Filed 2017-12-04
Tx date 2017-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-11-29
Tx date 2017-11-29
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,351
+263 vol
$5.14 each
4,500
Filed 2017-11-17
Tx date 2017-11-17
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$25,857
+3,900 vol
$6.63 each
943,353
Filed 2017-10-25
Tx date 2017-10-24
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,952
+1,750 vol
$5.69 each
9,150
Filed 2017-10-24
Tx date 2017-10-24
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$29,100
+5,000 vol
$5.82 each
5,000
Filed 2017-07-21
Tx date 2017-07-18
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-14,160
-2,000 vol
$7.08 each
4,237
Filed 2017-07-19
Tx date 2017-04-13
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-733,735.604
-106,904 vol
$6.86 each
2,770,909
Filed 2017-07-19
Tx date 2017-04-12
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-169,251.1184
-24,092 vol
$7.03 each
2,877,813
Filed 2017-07-19
Tx date 2017-04-11
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-3,217,351.6627
-445,487 vol
$7.22 each
2,901,905
Filed 2017-07-19
Tx date 2017-04-06
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,265,365.90
-193,000 vol
$6.56 each
3,347,392
Filed 2017-07-19
Tx date 2017-04-05
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,805,083.4958
-260,903 vol
$6.92 each
3,540,392
Filed 2017-07-19
Tx date 2017-04-04
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-656,672.87
-94,225 vol
$6.97 each
3,801,295
Filed 2017-07-19
Tx date 2017-04-03
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,227,495
-173,375 vol
$7.08 each
3,895,520
Filed 2017-07-19
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-3,934,089.41
-540,026 vol
$7.29 each
4,068,895
Filed 2017-07-19
Tx date 2017-05-10
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
59 - Exercise for cash

-615,575 vol
0
Filed 2017-07-19
Tx date 2017-05-10
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
59 - Exercise for cash
$-826,185.93
-115,188 vol
$7.17 each
615,575
Filed 2017-07-19
Tx date 2017-05-09
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
59 - Exercise for cash
$-995,809.5392
-140,168 vol
$7.10 each
730,763
Filed 2017-07-19
Tx date 2017-05-08
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
59 - Exercise for cash
$-1,284,574.748
-181,240 vol
$7.09 each
870,931
Filed 2017-07-19
Tx date 2017-05-05
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
59 - Exercise for cash
$-1,526,264.2116
-215,702 vol
$7.08 each
1,052,171
Filed 2017-07-19
Tx date 2017-05-04
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
59 - Exercise for cash
$-686,164.77
-96,507 vol
$7.11 each
1,267,873
Filed 2017-07-19
Tx date 2017-04-25
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-15,267,810.5881
-2,069,959 vol
$7.38 each
0
Filed 2017-07-19
Tx date 2017-04-20
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,300,889.897
-186,430 vol
$6.98 each
2,069,959
Filed 2017-07-19
Tx date 2017-04-20
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,874,735.98
-273,800 vol
$6.85 each
2,256,389
Filed 2017-07-19
Tx date 2017-04-18
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,196,913.056
-176,320 vol
$6.79 each
2,530,189
Filed 2017-07-19
Tx date 2017-04-17
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-437,437
-64,400 vol
$6.79 each
2,706,509
Filed 2017-07-19
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,735,232.719
-246,587 vol
$7.04 each
4,608,921
Filed 2017-07-19
Tx date 2017-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,735,232.719
-246,587 vol
$7.04 each
Filed 2017-07-19
Tx date 2017-03-29
$AUPH
Aurinia Pharmaceuticals Inc.
venBio Global Strategic Fund, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,460,923.74
-602,014 vol
$7.41 each
4,855,508
Filed 2017-07-14
Tx date 2017-07-05
$AUPH
Aurinia Pharmaceuticals Inc.
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,268,000
+280,000 vol
$8.10 each
280,000
Filed 2017-07-14
Tx date 2017-07-03
$AUPH
Aurinia Pharmaceuticals Inc.
Eglite, Erik
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-07-07
Tx date 2017-07-05
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants
$-20,539.55
-7,415 vol
$2.77 each
0
Filed 2017-07-07
Tx date 2017-07-05
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-46,492.05
-7,415 vol
$6.27 each
0
Filed 2017-07-07
Tx date 2017-07-05
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$20,539
+7,415 vol
$2.77 each
7,415
Filed 2017-07-06
Tx date 2017-06-21
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
7,400
Filed 2017-07-04
Tx date 2017-06-30
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-24,800
-4,000 vol
$6.20 each
23,769
Filed 2017-07-04
Tx date 2017-06-30
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-48,420
-6,000 vol
$8.07 each
17,769
Filed 2017-06-30
Tx date 2017-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-136,649.70
-21,186 vol
$6.45 each
0
Filed 2017-06-30
Tx date 2017-06-21
$AUPH
Aurinia Pharmaceuticals Inc.
ECONOMIDES, VASSILIKI NICHOLE (CELIA)
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
150,000
Filed 2017-06-30
Tx date 2017-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-16,399 vol
248,601
Filed 2017-06-30
Tx date 2017-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-16,399 vol
Filed 2017-06-30
Tx date 2017-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-105,773.55
-16,399 vol
$6.45 each
0
Filed 2017-06-30
Tx date 2017-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$60,020
+16,399 vol
$3.66 each
16,399
Filed 2017-06-30
Tx date 2017-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$59,200
+16,399 vol
$3.61 each
Filed 2017-06-28
Tx date 2017-05-08
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-06-28
Tx date 2017-06-23
$AUPH
Aurinia Pharmaceuticals Inc.
Milne, George M
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+50,000 vol
50,000
Filed 2017-06-27
Tx date 2017-06-23
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$70,000
+20,000 vol
$3.50 each
37,769
Filed 2017-06-27
Tx date 2017-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-43,400
-5,000 vol
$8.68 each
32,769
Filed 2017-06-27
Tx date 2017-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-19,650
-3,000 vol
$6.55 each
29,769
Filed 2017-06-27
Tx date 2017-06-23
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-69,040
-8,000 vol
$8.63 each
21,769
Filed 2017-06-27
Tx date 2017-06-23
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-26,240
-4,000 vol
$6.56 each
17,769
Filed 2017-06-27
Tx date 2017-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-39,540
-6,000 vol
$6.59 each
31,769
Filed 2017-06-27
Tx date 2017-06-26
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-35,160
-4,000 vol
$8.79 each
27,769
Filed 2017-06-27
Tx date 2017-06-23
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
51 - Exercise of options

-20,000 vol
455,776
Filed 2017-06-23
Tx date 2017-06-21
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-117,647.64
-13,200 vol
$8.91 each
625,499
Filed 2017-06-23
Tx date 2017-06-23
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-315,645.8844
-36,762 vol
$8.59 each
438,699
Filed 2017-06-23
Tx date 2017-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-283,012.605
-32,850 vol
$8.62 each
475,461
Filed 2017-06-23
Tx date 2017-06-21
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,015,363.7072
-117,188 vol
$8.66 each
508,311
Filed 2017-06-23
Tx date 2017-06-21
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-117,647.64
-13,200 vol
$8.91 each
625,499
Filed 2017-06-23
Tx date 2013-10-23
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation

-31,296,258 vol
638,699
Filed 2017-06-23
Tx date 2017-06-23
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-315,645.8844
-36,762 vol
$8.59 each
438,699
Filed 2017-06-23
Tx date 2017-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-283,012.605
-32,850 vol
$8.62 each
475,461
Filed 2017-06-23
Tx date 2017-06-21
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,015,363.7072
-117,188 vol
$8.66 each
508,311
Filed 2017-05-03
Tx date 2017-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$472,499
+50,000 vol
$9.45 each
210,000
Filed 2017-05-01
Tx date 2017-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Ayers, Gregory Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$189,000
+20,000 vol
$9.45 each
50,000
Filed 2017-04-28
Tx date 2017-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$189,000
+20,000 vol
$9.45 each
60,000
Filed 2017-04-28
Tx date 2017-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Rovinski, Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$189,000
+20,000 vol
$9.45 each
70,000
Filed 2017-04-28
Tx date 2017-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$189,000
+20,000 vol
$9.45 each
50,000
Filed 2017-04-28
Tx date 2017-04-26
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$189,000
+20,000 vol
$9.45 each
60,000
Filed 2017-03-22
Tx date 2017-03-20
$AUPH
Aurinia Pharmaceuticals Inc.
ILJIN Lifescience Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

-145,533 vol
0
Filed 2017-03-22
Tx date 2017-03-20
$AUPH
Aurinia Pharmaceuticals Inc.
ILJIN SNT Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+145,533 vol
1,405,419
Filed 2017-03-22
Tx date 2017-03-20
$AUPH
Aurinia Pharmaceuticals Inc.
ILJIN SNT Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$34,999,998
+5,185,185 vol
$6.75 each
12,800,039
Filed 2017-03-22
Tx date 2017-03-20
$AUPH
Aurinia Pharmaceuticals Inc.
ILJIN SNT Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

+4,586,606 vol
7,614,854
Filed 2017-03-22
Tx date 2017-03-20
$AUPH
Aurinia Pharmaceuticals Inc.
ILJIN Lifescience Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately

-4,586,606 vol
0
Filed 2017-03-02
Tx date 2017-02-16
$AUPH
Aurinia Pharmaceuticals Inc.
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$47,300
+10,000 vol
$4.73 each
40,000
Filed 2017-03-02
Tx date 2017-02-16
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$47,300
+10,000 vol
$4.73 each
40,000
Filed 2017-02-21
Tx date 2017-02-16
$AUPH
Aurinia Pharmaceuticals Inc.
Rovinski, Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$47,300
+10,000 vol
$4.73 each
50,000
Filed 2017-02-19
Tx date 2017-02-16
$AUPH
Aurinia Pharmaceuticals Inc.
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$47,300
+10,000 vol
$4.73 each
30,000
Filed 2017-02-15
Tx date 2017-02-14
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-3.75
-15 vol
$0.25 each
160,000
Filed 2017-02-15
Tx date 2017-02-13
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-2.00
-10 vol
$0.20 each
160,015
Filed 2017-02-15
Tx date 2017-02-09
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+65,000 vol
265,000
Filed 2017-02-15
Tx date 2017-02-09
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
11 - Acquisition or disposition carried out privately

+65,000 vol
Filed 2017-02-14
Tx date 2017-02-09
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$639,920
+152,000 vol
$4.21 each
339,439
Filed 2017-02-13
Tx date 2017-02-09
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$378,900
+90,000 vol
$4.21 each
277,439
Filed 2017-02-13
Tx date 2017-02-09
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$463,100
+110,000 vol
$4.21 each
297,537
Filed 2017-02-13
Tx date 2017-02-09
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$736,750
+175,000 vol
$4.21 each
475,776
Filed 2017-02-13
Tx date 2017-02-09
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$4,420,500
+1,050,000 vol
$4.21 each
1,270,000
Filed 2017-02-13
Tx date 2017-02-09
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
11 - Acquisition or disposition carried out privately

+65,000 vol
265,000
Filed 2017-02-10
Tx date 2017-02-09
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+55,000 vol
160,025
Filed 2017-01-27
Tx date 2017-01-24
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,835
-3,000 vol
$2.94 each
6,237
Filed 2017-01-27
Tx date 2017-01-25
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$-5.00
-25 vol
$0.20 each
105,025
Filed 2017-01-25
Tx date 2017-01-20
$AUPH
Aurinia Pharmaceuticals Inc.
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
20,000
Filed 2017-01-12
Tx date 2016-12-28
$AUPH
Aurinia Pharmaceuticals Inc.
ILJIN SNT Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
10 - Acquisition or disposition in the public market
$1,499,998
+666,666 vol
$2.25 each
1,259,886
Filed 2017-01-12
Tx date 2016-12-28
$AUPH
Aurinia Pharmaceuticals Inc.
ILJIN SNT Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,999,999
+1,333,333 vol
$2.25 each
3,028,248
Filed 2017-01-12
Tx date 2017-01-12
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
10 - Acquisition or disposition in the public market
$5.00
+50 vol
$0.10 each
105,050
Filed 2017-01-06
Tx date 2017-01-05
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,186
+770 vol
$2.84 each
770
Filed 2017-01-06
Tx date 2014-06-16
$AUPH
Aurinia Pharmaceuticals Inc.
Robertson, Stephen P.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-05
Tx date 2017-01-05
$AUPH
Aurinia Pharmaceuticals Inc.
Rowland, Charles
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$932.45
+434 vol
$2.15 each
334,865
Filed 2017-01-05
Tx date 2017-01-04
$AUPH
Aurinia Pharmaceuticals Inc.
Rowland, Charles
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$141,186
+65,714 vol
$2.15 each
334,431
Filed 2017-01-05
Tx date 2017-01-03
$AUPH
Aurinia Pharmaceuticals Inc.
Rowland, Charles
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$72,213
+33,852 vol
$2.13 each
268,717
Filed 2017-01-03
Tx date 2016-12-14
$AUPH
Aurinia Pharmaceuticals Inc.
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+10,000 vol
10,000
Filed 2017-01-03
Tx date 2016-11-16
$AUPH
Aurinia Pharmaceuticals Inc.
Randall, Lorin Jeffry
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-01-03
Tx date 2017-01-03
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,180
+2,000 vol
$2.09 each
9,237
Filed 2016-10-07
Tx date 2016-09-20
$AUPH
Aurinia Pharmaceuticals Inc.
ILJIN Lifescience Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
36 - Conversion or exchange

-333,333 vol
145,533
Filed 2016-10-07
Tx date 2016-09-20
$AUPH
Aurinia Pharmaceuticals Inc.
ILJIN Lifescience Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange
$833,332
+333,333 vol
$2.50 each
4,586,606
Filed 2016-09-26
Tx date 2016-09-16
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-1,000 vol
187,537
Filed 2016-09-01
Tx date 2016-08-30
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-4,000 vol
188,537
Filed 2016-09-01
Tx date 2016-08-30
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-10,000 vol
300,776
Filed 2016-08-11
Tx date 2016-08-03
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-10,000 vol
Filed 2016-08-11
Tx date 2016-08-03
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-4,000 vol
Filed 2016-08-11
Tx date 2016-08-03
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-4,000 vol
Filed 2016-08-11
Tx date 2016-08-03
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-10,000 vol
Filed 2016-08-09
Tx date 2016-08-03
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-4,000 vol
188,537
Filed 2016-08-09
Tx date 2016-08-03
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options

-10,000 vol
300,776
Filed 2016-07-28
Tx date 2016-07-22
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-4,545
-1,500 vol
$3.03 each
0
Filed 2016-07-28
Tx date 2016-07-21
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+40,000 vol
105,000
Filed 2016-06-28
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Cheoin Leisure Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
$1,399,999
+593,220 vol
$2.36 each
593,220
Filed 2016-06-28
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately
$205,401
+74,152 vol
$2.77 each
163,041
Filed 2016-06-28
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Cheoin Leisure Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$3,999,999
+1,694,915 vol
$2.36 each
1,694,915
Filed 2016-06-28
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Cheoin Leisure Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-28
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Cheoin Leisure Co., Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-27
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$500,001
+211,865 vol
$2.36 each
939,453
Filed 2016-06-24
Tx date 2016-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-24
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+7,415 vol
7,415
Filed 2016-06-24
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Rowland, Charles
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$500,001
+211,865 vol
$2.36 each
234,865
Filed 2016-06-24
Tx date 2014-07-29
$AUPH
Aurinia Pharmaceuticals Inc.
Rowland, Charles
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-24
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Rowland, Charles
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+74,153 vol
74,153
Filed 2016-06-24
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$49,998
+21,186 vol
$2.36 each
21,186
Filed 2016-06-24
Tx date 2016-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-23
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$9,999
+4,237 vol
$2.36 each
37,769
Filed 2016-06-23
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$9,999
+4,237 vol
$2.36 each
7,237
Filed 2016-06-23
Tx date 2016-01-04
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2016-06-23
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+1,483 vol
1,483
Filed 2016-06-23
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately
$9,999
+4,237 vol
$2.36 each
54,572
Filed 2016-06-23
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+1,483 vol
1,483
Filed 2016-06-23
Tx date 2016-06-22
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+1,483 vol
1,483
Filed 2016-06-18
Tx date 2016-06-17
$AUPH
Aurinia Pharmaceuticals Inc.
Rowland, Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$3,200,000
+1,000,000 vol
$3.20 each
1,040,000
Filed 2016-05-05
Tx date 2016-05-02
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
11 - Acquisition or disposition carried out privately

+200,000 vol
200,000
Filed 2016-05-05
Tx date 2016-04-29
$AUPH
Aurinia Pharmaceuticals Inc.
Dickerson, Bradley
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-04-01
Tx date 2016-03-31
$AUPH
Aurinia Pharmaceuticals Inc.
Zaruby, Stephen Walter
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$150,400
+40,000 vol
$3.76 each
1,230,717
Filed 2016-04-01
Tx date 2016-03-30
$AUPH
Aurinia Pharmaceuticals Inc.
Huizinga, Robert
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$156,400
+40,000 vol
$3.91 each
192,537
Filed 2016-04-01
Tx date 2016-03-30
$AUPH
Aurinia Pharmaceuticals Inc.
Bourgeault, Dennis
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$156,400
+40,000 vol
$3.91 each
310,776
Filed 2016-03-31
Tx date 2016-03-30
$AUPH
Aurinia Pharmaceuticals Inc.
Solomons, Neil
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$156,400
+40,000 vol
$3.91 each
187,439
Filed 2016-03-31
Tx date 2016-03-30
$AUPH
Aurinia Pharmaceuticals Inc.
Martin, Michael Robert
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$156,400
+40,000 vol
$3.91 each
187,439
Filed 2016-03-28
Tx date 2016-03-23
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-4,500
-1,500 vol
$3.00 each
1,500
Filed 2016-03-28
Tx date 2016-03-23
$AUPH
Aurinia Pharmaceuticals Inc.
Lee, Hyuek Joon
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$39,600
+10,000 vol
$3.96 each
30,000
Filed 2016-03-28
Tx date 2016-03-23
$AUPH
Aurinia Pharmaceuticals Inc.
Jayne, David Roland Walker
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$39,600
+10,000 vol
$3.96 each
30,000
Filed 2016-03-27
Tx date 2016-03-23
$AUPH
Aurinia Pharmaceuticals Inc.
Ayers, Gregory Martin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$39,600
+10,000 vol
$3.96 each
30,000
Filed 2016-03-25
Tx date 2016-03-23
$AUPH
Aurinia Pharmaceuticals Inc.
Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$39,600
+10,000 vol
$3.96 each
220,000
Filed 2016-03-24
Tx date 2016-03-23
$AUPH
Aurinia Pharmaceuticals Inc.
Rowland, Charles
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$39,600
+10,000 vol
$3.96 each
40,000
Filed 2016-03-24
Tx date 2016-03-23
$AUPH
Aurinia Pharmaceuticals Inc.
Rovinski, Benjamin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
$39,600
+10,000 vol
$3.96 each
40,000
Filed 2016-01-21
Tx date 2016-01-15
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,686
+1,000 vol
$1.69 each
3,000
Filed 2016-01-21
Tx date 2016-01-14
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,900
+1,000 vol
$2.90 each
3,000
Filed 2016-01-12
Tx date 2016-01-04
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
65,000
Filed 2016-01-12
Tx date 2016-01-04
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Holder: Triskel Health LLC (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
2,000
Filed 2016-01-12
Tx date 2016-01-04
$AUPH
Aurinia Pharmaceuticals Inc.
Gluck, Rashieda
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,000